CompletedNot applicableNCT00305149

Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

Studying Hodgkin lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rambam Health Care Campus
Principal Investigator
Ron Epelbaum, ND
Rambam health care center, Bruce Rappaport Faculty of Medicine Technion
Intervention
interim therapy scintigraphy study gallium scan or PET/CT(procedure)
Enrollment
130 enrolled
Eligibility
18-65 years · All sexes
Timeline
1999 – 2005

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00305149 on ClinicalTrials.gov

Other trials for Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Hodgkin lymphoma →

← Back to all trials